Antineoplastic Agents - Articles

Sort by: Newest Most Comments Relevance

Role of Chelating Agents by Ralph S. Certified Nurse Specialist

Posted Tue 23 Sep 2008 12:10am Role of Chelating Agents for Prevention, Intervention, and Treatment of Exposures to Toxic Metals R. A. Goyer, 1 M. G. Cherian, 2 M. M. Jones, 3 and J. R. Reigart 4 1 National Institute of Environmental Health Sciences, Research Triangle Park, NC 277009, USA; 2 University of Western Ontario, London N6A5C1, Canada; 3 Vanderbilt University, Na ... Read on »

Peptide and Peptidomimetic Inhibitors of Smoothened Protein as Anti-neoplastic Agents by nih.gov Posted Wed 09 Jun 2010 5:00pm Description of Invention: Cancer is caused by the improper regulation of certain signaling proteins in the cell. One of these pathways is the Hedgehog/Patched (HH/PTCH) pathway. Hedgehog is a secreted protein involved in the growth and development of embryonic cells. Patched is the receptor for hedgehog proteins and regulat ... Read on »

Being Sick and Breastfeeding by Becka S Healthy Living Professional

Posted Tue 03 Feb 2009 12:08am It’s that time of year. Everyone is sick. In my house we’ve passed around a cold for about a month now. The good news is, you do not have to stop breastfeeding just because you are sick. My little guy did come down with a cold but it wasn’t too bad. Most newborns who are being nursed have a higher immune system which prevents them from coming d ... Read on »

PSEUDOMEMBRANOUS COLITIS by Dr. Anshu Gupta Patient Expert

Posted Tue 02 Jun 2009 4:38pm Background: Pseudomembranous colitis (PMC) is a disease process commonly associated with hospitalization and prior antibiotic exposure. Initially thought to be caused by staphylococcal infection, PMC is now believed to be caused almost exclusively by toxins produced by Clostridium difficile. The identification of C difficile as a common eti ... Read on »

DHHS Updates Treatment Guidelines for HIV-Infected Adults, Teens by Poh Tin Tan Posted Fri 14 Jan 2011 11:36pm From Medscape Medical News Laurie Barclay, MD January 13, 2011 — The Department of Health and Human Services (DHHS) Panel on Antiretroviral Guidelines for Adults and Adolescents has updated guidelines for the use of antiretroviral (ARV) agents for HIV-1-infection in this population. The guidelines were posted online January 10. The DHHS ... Read on »

Parental Smoking Ups BP of Kids Aged Four and Five by Poh Tin Tan Posted Fri 14 Jan 2011 12:00am From Medscape Medical News Laurie Barclay, MD January 13, 2011 — The Department of Health and Human Services (DHHS) Panel on Antiretroviral Guidelines for Adults and Adolescents has updated guidelines for the use of antiretroviral (ARV) agents for HIV-1-infection in this population. The guidelines were posted online January 10. Th ... Read on »

Therapeutic effects of alpha-lipoic acid on bleomycin-induced pulmonary fibrosis in rats by Jan Posted Mon 29 Nov 2010 9:33pm Pulmonary fibrosis (PF) is a major side effect of radiotherapy and chemotherapy. Recent clinical trials, unfortunately, have failed to identify any therapeutic agent which has the potential to reduce the consequences of this devastating condition. Reactive oxygen species and tissue remodeling regulators, such as metalloproteinases (MMPs) and t ... Read on »

Gold Nanoparticles as a Potential Prostate Cancer Therapy by WorldHealth.net Posted Wed 15 Aug 2012 10:08pm Posted on Aug. 14, 2012, 6 a.m. in Men's Health Cancer Nanotechnology Currently, prostate cancer treatment typically cons ... Read on »

Chemoembolization for liver metastases by Mark Levin Posted Fri 31 Jul 2009 11:41am Transcatheter arterial chemoembolization (TACE) of the liver is a proposed alternative to conventional systemic or intra-arterial chemotherapy, and to various nonsurgical ablative techniques, to treat resectable and nonresectable tumors. The rationale for TACE is that infusions of viscous material containing one or more antineoplastic agents ma ... Read on »

Treatment Of Recurrent And Sensitive Ovarian Cancer by Shilah C. Azib Posted Mon 10 May 2010 5:40am Women who have ovarian cancer and have had surgery and chemotherapy as treatment and who develop recurrent cancer may be placed into one of three different groups referred to as A, B, C. Patients that are placed in group an are resistant to primary therapy and have tumor growth during treatment. Treatment suggested is non-cross ... Read on »